Skip to main content
  • Contact
  • Glossary
  • Subscribe
  • Search

PATH's Malaria Vaccine Initiative

Accelerating Malaria Vaccine Development

  • Malaria, vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D and Introduction
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
        • The decision-making framework for malaria vaccines
        • Economic analysis
        • Public health impact analysis
        • Sociocultural research
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Malaria, vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D and Introduction
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Home
  • Contact

Contact

PATH Washington DC

455 Massachusetts Avenue NW, Suite 1000

Washington, DC 20001 | USA 

Tel: 202.822.0033

Fax: 202.457.1466

Email: mvi_info [at] path.org

PATH Headquarters

2201 Westlake Avenue, Suite 200

Seattle, WA 98121 | USA 

Tel: 206.285.3500

Fax: 206.285.6619

Email: info [at] path.org

Website: www.path.org

Follow us

Mail
Twitter
  • Privacy policy
  • Copyright policy
  • Terms of use
© 2023 PATH
Website by Manta Ray Media